Answers are grounded in this paper and cite their sources.
bovine spongiform encephalopathy Creutzfeldt-Jakob disease Gerstmann-Sträussler-Scheinker syndrome fatal familial insomnia central nervous system. Transmissible spongiform encephalopathies are degenerative disorders of the central nervous system that occur naturally in man and in a variety of other animals. They include scrapie of sheep and goats, bovine spongiform encephalopathy (BSE)1 in cattle, and several human diseases such as Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI). Since its first recognition in 1986, BSE reached epidemic proportions in the UK (1Wilesmith J.W. Semin. Virol. 1992; 2: 239-245Google Scholar), and there is substantial evidence that a new variant of CJD may be because of consumption of BSE-contaminated products (2Will R.G. Ironside J.W. Zeidler M. Cousens S.N. Estibeiro K. Alperovitch A. Poser S. Pocchiari M. Hofman A. Smith P.G. Lancet. 1996; 347: 921-925Abstract PubMed Scopus (1891) Google Scholar). The unusual properties of the transmissible agent, or prion, early on suggested that it might be devoid of nucleic acid (3Alper T. Cramp W.A. Haig D.A. Clarke M.C. Nature. 1967; 214: 764-766Crossref PubMed Scopus (478) Google Scholar). Currently, the most widely accepted proposal is the “protein only” hypothesis, first outlined in general terms by Griffith (4Griffith J.S. Nature. 1967; 215: 1043-1044Crossref PubMed Scopus (898) Google Scholar) and enunciated in its updated and detailed form by Prusiner (5Prusiner S.B. Annu. Rev. Microbiol. 1989; 43: 345-374Crossref PubMed Scopus (241) Google Scholar, 6Prusiner S.B. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1993; 339: 239-254Crossref PubMed Scopus (34) Google Scholar). It proposes that the prion is identical with a conformational isoform of PrPC (5Prusiner S.B. Annu. Rev. Microbiol. 1989; 43: 345-374Crossref PubMed Scopus (241) Google Scholar), a normal host protein (7Oesch B. Westaway D. Wälchli M. McKinley M.P. Kent S.B. Aebersold R. Barry R.A. Tempst P. Teplow D.B. Hood L.E. Prusiner S.B. Weissmann C. Cell. 1985; 40: 735-746Abstract Full Text PDF PubMed Scopus (1251) Google Scholar, 8Chesebro B. Race R. Wehrly K. Nishio J. Bloom M. Lechner D. Bergstrom S. Robbins K. Mayer L. Keith J.M. Garon C. Haase A. Nature. 1985; 315: 331-333Crossref PubMed Scopus (344) Google Scholar, 9Basler K. Oesch B. Scott M. Westaway D. Wälchli M. Groth D.F. McKinley M.P. Prusiner S.B. Weissmann C. Cell. 1986; 46: 417-428Abstract Full Text PDF PubMed Scopus (643) Google Scholar) found predominantly on the outer surface of neurons. Introduction of the abnormal conformer into the organism would result in the conversion of PrPCinto a likeness of itself (Fig. 1). During the course of prion disease, a largely protease-resistant, aggregated form of PrP, designated PrPSc, accumulates mainly in brain (7Oesch B. Westaway D. Wälchli M. McKinley M.P. Kent S.B. Aebersold R. Barry R.A. Tempst P. Teplow D.B. Hood L.E. Prusiner S.B. Weissmann C. Cell. 1985; 40: 735-746Abstract Full Text PDF PubMed Scopus (1251) Google Scholar, 10McKinley M.P. Meyer R.K. Kenaga L. Rahbar F. Cotter R. Serban A. Prusiner S.B. J. Virol. 1991; 65: 1340-1351Crossref PubMed Google Scholar). Prusiner and co-workers (11Stahl N. Baldwin M.A. Teplow D.B. Hood L. Gibson B.W. Burlingame A.L. Prusiner S.B. Biochemistry. 1993; 32: 1991-2002Crossref PubMed Scopus (536) Google Scholar) proposed that PrPSc is the main or only constituent of the prion. Because no chemical differences were found between PrPC and PrPSc, the two species are believed to differ in their conformation. The three-dimensional structure of PrPC has been elucidated (12Riek R. Hornemann S. Wider G. Glockshuber R. Wüthrich K. FEBS Lett. 1997; 413: 282-288Crossref PubMed Scopus (664) Google Scholar) but not that of PrPSc; however, the β-sheet content of PrPSc was found to be high whereas that of PrPC is low (13Caughey B.W. Dong A. Bhat K.S. Ernst D. Hayes S.F. Caughey W.S. Biochemistry. 1991; 30: 7672-7680Crossref PubMed Scopus (742) Google Scholar). Because the ratio of infectious units to PrPSc molecules is only about 1:100,000 (14Bolton D.C. Rudelli R.D. Currie J.R. Bendheim P.E. J. Gen. Virol. 1991; 72: 2905-2913Crossref PubMed Scopus (63) Google Scholar), the structure of the PrP molecule actually associated with infectivity cannot be definitively inferred. For this reason the PrP species responsible for infectivity is presently better designated as PrP* (15Weissmann C. Nature. 1991; 349: 569-571Crossref PubMed Scopus (111) Google Scholar). The conclusion that some form of PrP is the essential (perhaps only) constituent of the infectious agent is based on compelling biochemical and genetical evidence (5Prusiner S.B. Annu. Rev. Microbiol. 1989; 43: 345-374Crossref PubMed Scopus (241) Google Scholar, 16Weissmann C. FEBS Lett. 1996; 389: 3-11Crossref PubMed Scopus (145) Google Scholar). Although most cases of human prion disease are sporadic, about 10% are familial and linked to one of a number of mutations in thePrP gene (Fig. 2) (for reviews see Refs. 17Baker H.F. Ridley R.M. Neurodegeneration. 1992; 1: 3-16Google Scholar and 18Goldfarb L.G. Brown P. Cervenakova L. Gajdusek D.C. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1994; 343: 379-384Crossref PubMed Scopus (37) Google Scholar). It is believed that these mutations allow spontaneous conversion of PrPC into PrPSc with a frequency sufficient to cause disease within the lifetime of the individual (5Prusiner S.B. Annu. Rev. Microbiol. 1989; 43: 345-374Crossref PubMed Scopus (241) Google Scholar, 19Prusiner S.B. Science. 1991; 252: 1515-1522Crossref PubMed Scopus (1745) Google Scholar). Sporadic CJD could be attributed to rare instances of spontaneous conversion of PrPC into PrPSc or rare somatic mutations in the Prnp gene. In both cases the initial conversion would be followed by autocatalytic propagation. Mice overexpressing a murine PrP transgene with a mutation corresponding to the human GSS mutation Pro-102 → Leu spontaneously contract a lethal scrapie-like disease, and it has been reported that this disease can be transmitted to mice expressing the same mutant transgene at lower levels, which do not lead to spontaneous disease (20Hsiao K.K. Groth D. Scott M. Yang S.L. Serban H. Rapp D. Foster D. Torchia M. DeArmond S.J. Prusiner S.B. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 9126-9130Crossref PubMed Scopus (272) Google Scholar, 21Telling G.C. Haga T. Torchia M. Tremblay P. DeArmond S.J. Prusiner S.B. Genes Dev. 1996; 10: 1736-1750Crossref PubMed Scopus (235) Google Scholar). The “protein only” hypothesis predicts that in the absence of PrPC mice should be resistant to scrapie and fail to multiply the infectious agent. Mice devoid of PrP (Prnp o/o) were generated by homologous recombination and found to be essentially normal (22Büeler H. Fischer M. Lang Y. Bluethmann H. Lipp H.-P. DeArmond S.J. Prusiner S.B. Aguet M. Weissmann C. Nature. 1992; 356: 577-582Crossref PubMed Scopus (1437) Google Scholar). When challenged with mouse prions, mice devoid of PrP were completely protected against scrapie disease, and prions failed to accumulate in spleen and brain, in contrast to wild-type mice (23Büeler H. Aguzzi A. Sailer A. Greiner R.A. Autenried P. Aguet M. Weissmann C. Cell. 1993; 73: 1339-1347Abstract Full Text PDF PubMed Scopus (1809) Google Scholar, 24Sailer A. Büeler H. Fischer M. Aguzzi A. Weissmann C. Cell. 1994; 77: 967-968Abstract Full Text PDF PubMed Scopus (246) Google Scholar). Introduction of murinePrnp transgenes into Prnp o/o mice resulted in several lines with varying expression levels of PrPC, which were susceptible to mouse prions; the higher the PrPC content of the brain, the shorter the incubation times (25Fischer M. Rülicke T. Raeber A. Sailer A. Moser M. Oesch B. Brandner S. Aguzzi A. Weissmann C. EMBO J. 1996; 15: 1255-1264Crossref PubMed Scopus (780) Google Scholar). The demonstration that disruption of the PrP gene confers resistance to scrapie and that reintroduction of a PrP-encoding transgene restores susceptibility paved the way to reverse genetics of PrP, that is the introduction of deletions or mutations into thePrnp gene and determination of the capacity of the modified gene to confer susceptibility to scrapie to a PrP knockout mouse. Transgenes encoding PrP with deletions extending to codon 93, but not to 106, restored susceptibility to scrapie (25Fischer M. Rülicke T. Raeber A. Sailer A. Moser M. Oesch B. Brandner S. Aguzzi A. Weissmann C. EMBO J. 1996; 15: 1255-1264Crossref PubMed Scopus (780) Google Scholar). 2D. Shmerling and E. Flechsig, unpublished results. Acquired forms of prion diseases are mostly transmitted through oral uptake of prions or peripheral administration, raising the question as to how the agent finds its way to the CNS. Prnp +/+ neuroectodermal tissue introduced into the brain of newly born Prnp o/o mice develops into differentiated Prnp +/+ nervous tissue. Intracerebral inoculation of such engrafted mice leads to typical scrapie pathology in the graft but not in the surroundingPrnp o/o tissue (26Brandner S. Isenmann S. Raeber A. Fischer M. Sailer A. Kobayashi Y. Marino S. Weissmann C. Aguzzi A. Nature. 1996; 379: 339-343Crossref PubMed Scopus (718) Google Scholar). However, because intraperitoneal inoculation of these mice does not lead to pathology in the Prnp +/+ graft, transport of prions from the periphery to the CNS is seen to require interposed PrP-bearing tissue (27Brandner S. Raeber A. Sailer A. Blattler T. Fischer M. Weissmann C. Aguzzi A. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 13148-13151Crossref PubMed Scopus (220) Google Scholar). It has also been shown that Prnp +/+immunodeficient mice lacking mature B cells fail to transport prions from the periphery to the CNS, suggesting a role of the lymphoreticular system in transport (28Klein M.A. Frigg R. Flechsig E. Raeber A.J. Kalinke U. Bluethmann H. Bootz F. Suter M. Zinkernagel R.M. Aguzzi A. Nature. 1997; 390: 687-690Crossref PubMed Scopus (446) Google Scholar). It is believed that the follicular dendritic cells, which depend on B cells for their maintenance in a mature state, are the site of prion replication in the spleen (29Kitamoto T. Muramoto T. Mohri S. Dohura K. Tateishi J. J. Virol. 1991; 65: 6292-6295Crossref PubMed Google Scholar, 30McBride P.A. Eikelenboom P. Kraal G. Fraser H. Bruce M.E. J. Pathol. 1992; 168: 413-418Crossref PubMed Scopus (212) Google Scholar) and that transport to the CNS is, in addition, dependent on the peripheral nervous system (31Kimberlin R.H. Walker C.A. J. Gen. Virol. 1980; 51: 183-187Crossref PubMed Scopus (105) Google Scholar). Prions are transmitted from one species to another much less efficiently, if at all, than within the same species and only after prolonged incubation times. In the case of prion transmission from hamsters to mice, this so-called species barrier was overcome by introducing hamster Prnp transgenes into recipient wild-type mice (32Prusiner S.B. Scott M. Foster D. Pan K.M. Groth D. Mirenda C. Torchia M. Yang S.L. Serban D. Carlson G.A. Hoppe P.C. Westaway D. DeArmond S.J. Cell. 1990; 63: 673-686Abstract Full Text PDF PubMed Scopus (726) Google Scholar, 33Scott M. Foster D. Mirenda C. Serban D. Coufal F. Wälchli M. Torchia M. Groth D. Carlson G. DeArmond S.J. Westaway D. Prusiner S. Cell. 1989; 59: 847-857Abstract Full Text PDF PubMed Scopus (581) Google Scholar). Importantly, the properties of the prions produced in these transgenic mice corresponded to the prion species used for inoculation (32Prusiner S.B. Scott M. Foster D. Pan K.M. Groth D. Mirenda C. Torchia M. Yang S.L. Serban D. Carlson G.A. Hoppe P.C. Westaway D. DeArmond S.J. Cell. 1990; 63: 673-686Abstract Full Text PDF PubMed Scopus (726) Google Scholar), that is infection with hamster prions led to production of hamster prions, but infection with mouse prions gave rise to mouse prions. Within the framework of the “protein only” hypothesis this means that hamster PrPC but not murine PrPC (which differs from the former by 10 amino acids) is a suitable substrate for conversion to hamster PrPSc by hamster prions and vice versa. Interestingly, susceptibility of the mouse to prions from other species, such as hamster, mouse, or man, is increased when the PrP transgenes are introduced into a PrP knockout mouse, suggesting that the resident murine gene inhibits the propagation of the alien prions (23Büeler H. Aguzzi A. Sailer A. Greiner R.A. Autenried P. Aguet M. Weissmann C. Cell. 1993; 73: 1339-1347Abstract Full Text PDF PubMed Scopus (1809) Google Scholar). Dickinson and colleagues (34Dickinson A.G. Meikle V.M. Genet. Res. 1969; 13: 213-225Crossref PubMed Scopus (104) Google Scholar, 35Bruce M.E. Fraser H. McBride P.A. Scott J.R. Dickinson A.G. Prusiner S.B. Collinge J. Powell J. Anderton B. Prion Diseases of Humans and Animals. Ellis Horwood, New York1992: 497-508Google Scholar) showed that many distinct strains of scrapie prions can be derived from sheep isolates. These strains differ by their incubation times in various inbred mouse lines and by the lesion patterns they occasion in the affected brains. Interestingly, different strains can be propagated in one inbred mouse strain (homozygous with regard to its PrP gene) (35Bruce M.E. Fraser H. McBride P.A. Scott J.R. Dickinson A.G. Prusiner S.B. Collinge J. Powell J. Anderton B. Prion Diseases of Humans and Animals. Ellis Horwood, New York1992: 497-508Google Scholar). Within the framework of the protein only hypothesis this is at first blush puzzling, because it means that one and the same polypeptide chain is able to mediate different strain phenotypes. The conformational hypothesis proposes that each strain is associated with a different conformation of PrPSc (or PrP*) and that each of these can convert the PrPC of its host into a likeness of itself (19Prusiner S.B. Science. 1991; 252: 1515-1522Crossref PubMed Scopus (1745) Google Scholar). Marsh and colleagues (36Bessen R.A. Marsh R.F. J. Virol. 1994; 68: 7859-7868Crossref PubMed Google Scholar) showed that the PrPSc species associated with two hamster-adapted scrapie strains, HY and DY, are cleaved to products of different length by proteinase K; the different susceptibility to protease is readily explained by different conformations. Similar findings were made with other prion strains propagated in the mouse (37Telling G.C. Parchi P. DeArmond S.J. Cortelli P. Montagna P. Gabizon R. Mastrianni J. Lugaresi E. Gambetti P. Prusiner S.B. Science. 1996; 274: 2079-2082Crossref PubMed Scopus (752) Google Scholar, 38Hill A.F. Desbruslais M. Joiner S. Sidle K.C.L. Gowland I. Collinge J. Doey L.J. Lantos P. Nature. 1997; 389: 448-450Crossref PubMed Scopus (1204) Google Scholar). Moreover, PrPSc of certain strains differ in the ratio of the diglycosylated to the monoglycosylated form (39Collinge J. Sidle K.C. Meads J. Ironside J. Hill A.F. Nature. 1996; 383: 685-690Crossref PubMed Scopus (1589) Google Scholar). Is it possible that a dozen different strains of prions can differ in regard to the conformation of the PrPSc they are associated with and that all these conformations can “breed true”? It has recently been claimed that PrPSc molecules of as many as eight different strains could be differentiated by virtue of their relative affinity for a monoclonal antibody directed against an epitope that is fully available in PrPC but partially occluded in PrPSc. In addition, some strains differed in their susceptibility to denaturation by guanidinium chloride, adding further credibility to the conformational hypothesis of strain specificity (40Safar J. Wille H. Itri V. Groth D. Serban H. Torchia M. Cohen F.E. Prusiner S.B. Nat. Med. 1998; 4: 1157-1165Crossref PubMed Scopus (1077) Google Scholar). Conversion of PrPC to PrPSc in scrapie-infected cells is a late post-translational process, occurring after PrPC has reached its normal extracellular location or thereafter (41Caughey B. Raymond G.J. J. Biol. Chem. 1991; 266: 18217-18223Abstract Full Text PDF PubMed Google Scholar). Why is spontaneous formation of PrPSc an extremely rare event and how does scrapie infection promote conversion? The “refolding model” (Fig.3 A) proposes that conversion requires that PrPC be unfolded to some extent and refolded under the influence of a PrPSc molecule (19Prusiner S.B. Science. 1991; 252: 1515-1522Crossref PubMed Scopus (1745) Google Scholar), a process that would have to overcome a high activation energy barrier and might require a chaperone and an energy source. The “nucleation model” (Fig. 3 B) proposes that PrPC is in equilibrium with PrPSc (or a precursor thereof) and that PrPSc is only stabilized when it adds onto a crystal-like seed or aggregate of PrPSc. If a stable aggregate needs to consist minimally of a substantial number of PrPScmolecules, then its spontaneous formation would be a very rare event. However, once a seed is present, monomer addition could ensue at a rapid rate (42Gajdusek D.C. J. Neuroimmunol. 1988; 20: 95-110Abstract Full Text PDF PubMed Scopus (123) Google Scholar, 43Brown P. Goldfarb L.G. Gajdusek D.C. Lancet. 1991; 337: 1019-1022Abstract PubMed Scopus (117) Google Scholar, 44Jarrett J.T. Lansbury P.J. Cell. 1993; 73: 1055-1058Abstract Full Text PDF PubMed Scopus (1917) Google Scholar). Trapping of PrP by essentially irreversible aggregation would drive the bulk conversion process. The proposed process is akin to the assembly of (protease-sensitive) flagellin to (protease-resistant) flagellar filaments (45Aizawa S.-I. Vonderviszt F. Ishima R. Akasaka K. J. Mol. Biol. 1990; 211: 673-677Crossref PubMed Scopus (62) Google Scholar). Interestingly, the same flagellin molecule can assemble into two types of flagella, depending on the provenance of the seed (46Asakura S. Eguchi G. Iino T. J. Mol. Biol. 1966; 16: 302-316Crossref PubMed Scopus (64) Google Scholar), thereby providing an analogy for conformationally determined prion strain specificity. Caughey and colleagues (47Kocisko D.A. Come J.H. Priola S.A. Chesebro B. Raymond G.J. Lansbury P.T. Caughey B. Nature. 1994; 370: 471-474Crossref PubMed Scopus (790) Google Scholar) have shown that incubation of35S-labeled PrPC with PrPSc yields a radioactive product that resembled PrPSc with regard to its protease resistance. The conversion reaction exhibited the “species specificity” observed in vivo; thus PrPC from mouse was readily converted to protease resistance by murine PrPSc but poorly by bovine PrPSc and vice versa (48Raymond G.J. Hope J. Kocisko D.A. Priola S.A. Raymond L.D. Bossers A. Ironside J. Will R.G. Chen S.G. Petersen R.B. Gambetti P. Rubenstein R. Smits M.A. Lansbury Jr., P.T. Caughey B. Nature. 1997; 388: 285-288Crossref PubMed Scopus (237) Google Scholar). Moreover, even strain specificity has been demonstrated in this type of reaction, in that labeled PrPC incubated with PrPSc from the DY or the HY hamster transmissible mink encephalopathy strains described above yielded labeled PrPSc with the properties typical for the input PrPSc (49Bessen R.A. Kocisko D.A. Raymond G.J. Nandan S. Lansbury P.T. Caughey B. Nature. 1995; 375: 698-700Crossref PubMed Scopus (460) Google Scholar). Despite efforts by several groups, it has not been possible to demonstrate net synthesis of infectivity over the background by the PrPSc Although each individual of evidence described above could be explained in several the of the proposal that the prion is or of a molecule or and that nucleic acid is not an essential the one could to for the protein only hypothesis would be the demonstration that PrPC can be converted not only into a form but to infectious scrapie agent under in to be in the and the for the conversion reaction, the transport of the prion from periphery to CNS, and the of to but a a early of prion disease and at or the disease in are one may the question cause other diseases or in Although several human diseases by formation are of have been Interestingly, two have been to protein the and the R.B. Science. 1994; PubMed Scopus Google Scholar), and have new for the of this
No takes yet. Share an insight, caveat, or question.
Charles Weissmann (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: